Patent Assignment
Reel/Frame 058305/0683
Assignment of Assignor's Interest
Recorded: 2021-12-06
Pages: 11
Assignor
SALIX PHARMACEUTICALS, LTD.
Executed: 2018-11-14
Assignee
SALIX PHARMACEUTICALS, INC.
400 SOMERSET CORPORATE BLVD., BRIDGEWATER, NEW JERSEY, 08807
Covered Properties
(2)
Solid Dispersion Forms of Rifaximin
Solid Dispersion Forms of Rifaximin
Related Assignments
(6)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Dec 6, 2021
From: GOLDEN, PAM; KABIR, MOHAMMED A.
To: SALIX PHARMACEUTICALS, LTD.
Reel/Frame 058305/0614 →
Security Interest
Mar 30, 2022
From: BAUSCH+LOMB IRELAND LIMITED; BAUSCH HEALTH IRELAND LIMITED; BAUSCH & LOMB INCORPORATED; SALIX PHARMACEUTICALS, INC.
To: BARCLAYS BANK PLC, AS COLLATERAL AGENT
Reel/Frame 059446/0670 →
Security Interest
Mar 30, 2022
From: BAUSCH+LOMB IRELAND LIMITED; BAUSCH HEALTH IRELAND LIMITED; BAUSCH & LOMB INCORPORATED; SALIX PHARMACEUTICALS, INC.
To: THE BANK OF NEW YORK MELLON, AS NOTES COLLATERAL AGENT
Reel/Frame 059446/0722 →
Security Agreement (First Lien)
Oct 4, 2022
From: BAUSCH HEALTH US, LLC; BAUSCH HEALTH AMERICAS, INC.; MEDICIS PHARMACEUTICAL CORPORATION; ORAPHARMA, INC.
To: THE BANK OF NEW YORK MELLON, AS NOTES COLLATERAL AGENT
Reel/Frame 061595/0066 →
Security Agreement (Second Lien)
Oct 5, 2022
From: BAUSCH HEALTH US, LLC; BAUSCH HEALTH AMERICAS, INC.; MEDICIS PHARMACEUTICAL CORPORATION; ORAPHARMA, INC.
To: THE BANK OF NEW YORK MELLON, AS NOTES COLLATERAL AGENT
Reel/Frame 061606/0468 →
Release of Security Interest
Apr 8, 2025
From: BARCLAYS BANK PLC, AS COLLATERAL AGENT
To: SOLTA MEDICAL, INC.; PRECISION DERMATOLOGY, INC.; BAUSCH HEALTH IRELAND LIMITED (F/K/A/ VALEANT PHARMACEUTICALS IRELAND LIMITED); SALIX PHARMACEUTICALS, INC.
Reel/Frame 070778/0199 →